ILS Gummies, LLC

Based in the US, ILS Gummies, LLC specializes in the production of nutraceutical gummies designed for health and wellness applications, focusing on innovative flavor systems and unique delivery methods. ILS Gummies, LLC, founded in 2022, operates from McKinney, US, providing nutraceutical gummy products. The company was co-founded by Andrew Riess and Shane Davis. Andrew Riess's previous entrepreneurial endeavors are not specified.

ILS Gummies has engaged in 2 deals, with the most recent one occurring on February 3, 2026. ILS Gummies specializes in the production of nutraceutical gummies, utilizing innovative delivery systems designed for health and wellness applications. Their core offerings focus on formulating unique flavor systems that effectively complement active ingredients, thus enhancing the overall consumer experience. The company collaborates closely with partners to co-develop proprietary products tailored to specific market needs.

ILS Gummies primarily serves a diverse client base, including health and wellness brands, retailers, and direct-to-consumer markets. Their products are distributed across various geographical regions, including North America and select international markets, targeting consumers seeking convenient and effective health solutions. Revenue generation at ILS Gummies is structured around business-to-business (B2B) transactions, where the company partners with various health and wellness brands. Clients engage in partnerships to produce customized products, leading to a steady stream of orders based on client specifications.

The transaction structure typically involves agreements for bulk orders of nutraceutical gummies, ensuring a reliable supply chain and consistent revenue flow. Pricing strategies for these products are defined by the complexity of formulations and flavor profiles, allowing for flexibility in meeting diverse client demands. The company’s flagship offerings are central to its revenue model, as they focus on high-quality, differentiated products that meet industry standards and consumer expectations. In February 2026, ILS Gummies, LLC secured an investment from a consortium of investors led by Edgehill Management, which will enable the company to scale its manufacturing capacity and enhance operational capabilities.

This funding will support the development of new products tailored to expanding consumer needs. ILS Gummies plans to target new markets, including international regions that are currently underserved, aiming for a significant rollout by the end of 2027. This strategic expansion is designed to strengthen the company's position in the nutraceutical market and meet long-term customer demand.